Description
Catheters are thin tube medical devices made of high graded materials. Catheters are inserted into the body for treatment of various diseases or while performing surgeries. This process is called as catheterization. They are used in the treatment of diseases such as cardiovascular, neurovascular, urology, and many more. Catheters are inserted into the body for the administration of various liquid medication or gas for the treatment of diseases.
The over-the-wire micro-guide catheter market can be driven by growing preference towards minimally invasive surgical procedures, technological advancements in over-the-wire micro-guide catheters, increasing number of patients suffering from cardiac and neurovascular disorders, and increasing geriatric population.
The introduction of catheters has completely changed the treatment scenario of many surgeries such as cardiac surgery and many others. The minimally invasive cardiac surgery can be less disruptive and traumatic for the human body, making it particularly beneficial in elderly patients who are at an increased risk of surgical complications. According to the American Heart Association and Stroke Statistics (2017), about 92.1 million American adults are living with cardiovascular diseases and strokes, and cardiovascular diseases are the major causes of death globally which accounted for 17.9 million deaths per year in 2015.
The global over-the-wire micro-guide catheter market is segmented based on application and end-user.
Based on application, the market is further segmented into cardiovascular and neurovascular.
Based on end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and research and academic institutes.
The global over-the-wire micro-guide catheter market was valued at USD 102.60 million in 2017 and is expected to register a CAGR of 9.37% over the forecast period.
Key Players
ASAHI INTECC Company Limited, Boston Scientific Corporation, Cook Medical, Medtronic plc., Merit Medical Systems Inc., Integer Holdings Corporation, Terumo Europe N.V., Penumbra Inc, Koninklijke Philips N.V, Cardinal Health, Teleflex Incorporated, DePuy Synthes, and Enki – Microtubes
Study objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global over-the-wire micro-guide catheter market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market, and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global over-the-wire micro-guide catheter market
• To provide a detailed analysis of the value chain and supply chain of the global over-the-wire micro-guide catheter market
Target Audience
• Medical Devices Manufacturers
• Medical Devices Distributors
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
Key Findings
• The global over-the-wire micro-guide catheter market is expected to reach USD 175.67 million by 2023 at a CAGR of 9.37% from 2018 to2023
• On the basis of application, the cardiovascular segment accounted for the major market share of 58.1% and was valued at USD 59.60 million in 2017
• On the basis of end-user, hospitals and clinics accounted for a major market share of 45% in 2017
• The Americas is expected to hold the largest share of the global over-the-wire micro-guide catheter market which is expected to reach USD 71.05 million by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 9.84 % from 2018 to 2023
Regional Analysis
• Americas
o North America
US
Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia Pacific
• Middle East & Africa
o Middle East
o Africa
Table of Contents
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing preference towards minimally invasive surgical procedures
5.2.2 Technological advancements in over-the-wire micro-guide catheters
5.2.3 Increasing number of patients suffering from cardiac and neurovascular disorders
5.2.4 Increasing geriatric population
5.3 Restraints
5.3.1 Risk of infections may hamper the market
5.3.2 Lack of skilled physicians
5.4 Opportunities
5.4.1 Increase in research & innovations
5.5 Challenges
5.5.1 Regulatory compliance and government support
6 Market Factor Analysis
6.1 Value Chain Analysis
6.1.1 R&D and Designing
6.1.2 Manufacturing
6.1.3 Distribution & Sales
6.1.4 Post-Sales Services
6.2 Porter’s Five Forces Model
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Buyers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitutes
6.2.5 Intensity of rivalry
6.3 Demand & Supply: Gap Analysis
6.4 Pricing Analysis
7 Global Over-the-wire Micro-Guide Catheter Market, by Application
7.1 Introduction
7.2 Cardiovascular
7.3 Neurovascular
8 Global Over-the-wire Micro-Guide Catheter Market, by End-User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgical Centers
8.4 Research & Academic Institutes
9 Global Over-the-wire Micro-Guide Catheter Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K.
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Introduction
10.2 Company Share Analysis
11 Company Profile
11.1 ASAHI INTECC Company Limited
11.1.1 Company Overview
11.1.2 Financial Overview:
11.1.3 Products Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Boston Scientific Corporation
11.2.1 Company Overview
11.2.2 Financial Overview:
11.2.3 Products Offering
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Cook Medical
11.3.1 Company Overview
11.3.2 Financial Overview:
11.3.3 Products Offering
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key strategy
11.4 Medtronic plc.
11.4.1 Company Overview
11.4.2 Financial Overview:
11.4.3 Products Offering
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Merit Medical Systems Inc.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offering
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Integer Holdings Corporation
11.6.1 Company Overview
11.6.2 Financial Overview:
11.6.3 Products Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Terumo Europe N.V.
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offering
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Penumbra Inc
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offering
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Koninklijke Philips N.V
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offering
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Cardinal Health
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offering
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Teleflex Incorporated
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products Offering
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 DePuy Synthes
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products Offering
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
11.13 Enki – Microtubes
11.13.1 Company Overview
11.13.2 Financial Overview
11.13.3 Products Offering
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.13.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print
